Cooperative Agreement for the Provider’s Clinical Support System - Medication Assisted Treatment

Short Title: 
PCSS-MAT
Initial Announcement
Funding Opportunity Announcement (FOA) Information
FOA Number: 
TI-16-003
Posted on Grants.gov: 
Thursday, November 5, 2015
Application Due Date: 
Monday, January 11, 2016
Catalog of Federal Domestic Assistance (CFDA) Number: 
93.243
Intergovernmental Review (E.O. 12372): 
Applicants must comply with E.O. 12372 if their state(s) participates. Review process recommendations from the State Single Point of Contact (SPOC) are due no later than 60 days after application deadline.
Public Health System Impact Statement (PHSIS) / Single State Agency Coordination: 
Applicants must send the PHSIS to appropriate State and local health agencies by application deadline. Comments from Single State Agency are due no later than 60 days after application deadline.
Description

The Substance Abuse and Mental Health Services Administration (SAMHSA), Center for Substance Abuse Treatment (CSAT) is accepting applications for fiscal year (FY) 2016 Cooperative Agreement for the Provider’s Clinical Support System - Medication Assisted Treatment (Short Title: PCSS-MAT) grant. The purpose of this program is to expand on the Drug Addiction Treatment Act (DATA) of 2000 and continue SAMHSA’s currently funded PCSS-MAT initiative. Although the current initiative has provided multiple trainings and mentoring support, there still remains a significant need to increase the number of healthcare providers to address the nation’s lack of adequate care. The PCSS-MAT program will continue to provide up-to-date and evidence-based information to support the training of health professionals and to address the complex issues of addiction.

Eligibility

Eligibility is limited to the national professional medical organizations authorized by the Drug Addiction Treatment Act of 2000 (DATA) to carry out the training of providers desiring to prescribe and/or dispense FDA approved schedule III medications for the addictive disorders. These organizations are the American Society of Addiction Medicine (ASAM), the American Academy of Addiction Psychiatry (AAAP), the American Medical Association (AMA), the American Osteopathic Academy of Addiction Medicine (AOAAM), and the American Psychiatric Association (APA). Any of these entities may apply individually; they may also apply as a consortium comprised of all or several of the eligible organizations. If a consortium is formed for this purpose, a single organization in the consortium must be the legal applicant, the recipient of the award, and the entity legally responsible for satisfying the grant requirements.

Award Information
Funding Mechanism: 
Cooperative Agreement
Anticipated Total Available Funding: 
$1,000,000
Anticipated Number of Awards: 
1
Anticipated Award Amount: 
Up to $1,000,000
Length of Project: 
Up to 3 years
Cost Sharing/Match Required?: 
No

Proposed budgets cannot exceed $1 million in total costs (direct and indirect) in any year of the proposed project.  Annual continuation awards will depend on the availability of funds, grantee progress in meeting project goals and objectives, timely submission of required data and reports, and compliance with all terms and conditions of award.

Contact Information
Program Issues

Anthony Campbell RPH, D.O.
Medical Officer
Division of Pharmacologic Therapy, Center for Substance Abuse Treatment
Substance Abuse and Mental Health Services Administration
1 Choke Cherry Road
Room 7-1019
Rockville, Maryland 20857
(240) 276-2702
Tony.campbell@samhsa.hhs.gov  

Grants Management and Budget Issues

Eileen Bermudez
Office of Financial Resources, Division of Grants Management
Substance Abuse and Mental Health Services Administration
1 Choke Cherry Road
Room 7-1091
Rockville, Maryland 20857
(240) 276-1412
FOACSAT@samhsa.hhs.gov

Application Materials

You must respond to the requirements in both the FOA PART I and PART II when preparing your application.

Useful Information for Applicants
Last Updated: 11/16/2015